Sculptor Capital LP Adds 56,000 Shares of Helix Acquisition Corp III (HLXC) in Latest 13F Filing
Transaction Overview: Sculptor Capital LP Increases Stake in Helix Acquisition Corp III
On Oct. 6, 2026, Sculptor Capital LP disclosed an addition of 56,000 shares of Helix Acquisition Corp III (HLXC) at a price of $10.54 per share. Following this transaction, the firm's total holdings in the blank check company reached 928,563 shares. This move represents a 6.42% increase in position size and a 0.01% change in total share count. The trade reflects a continued accumulation strategy by the institutional investor, bringing the total value of the position to approximately $9.79 million based on the transaction price. HLXC now accounts for 0.1% of Sculptor Capital LP's equity portfolio, while the firm's stake represents 5.23% of the stock's total shares outstanding. This level of ownership indicates a significant, albeit not controlling, interest in the SPAC's outstanding equity.
Guru Profile: Sculptor Capital LP
Sculptor Capital LP is an institutional investment firm headquartered at 9 West 57th Street, 39th Floor, New York, NY 10019. The firm manages a substantial equity portfolio valued at $9.56 billion, spread across 344 distinct stock holdings. Its investment strategy appears focused on high-growth sectors, with the largest allocations in Technology and Communication Services. Key positions within the portfolio include:
- Advanced Micro Devices Inc
- Bruker Corp
- Liberty Media Corp
- Taiwan Semiconductor Manufacturing Co Ltd
- Sotera Health Co
The firm's diversified approach and significant capital deployment make its 13F filings closely watched by market participants seeking insights into institutional capital flows.
Traded Company Profile: Helix Acquisition Corp III
Helix Acquisition Corp III is a blank check company incorporated in the United States and listed on the Nasdaq under the ticker HLXC. Organized as a special purpose acquisition company (SPAC), it was formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more operating businesses. The company does not conduct commercial operations, generate product revenue, or serve customers; instead, it holds proceeds from its initial public offering and private placements in trust and earns interest income on those funds. The stock has a market cap of $229.42 million and trades at $10.40, with an IPO date of Jan. 23, 2026.
Valuation and Financial Metrics
From a valuation perspective, HLXC presents a mixed picture typical of pre-merger SPACs. The stock has a PE ratio of 105.05, a GF Score of 16/100, and a GF Valuation of "No Data: Cannot Be Evaluated," indicating insufficient data to determine intrinsic value. The GF Score of 16/100 places the stock in the lowest tier for long-term performance potential. The stock's Financial Strength rank is 7/10, Profitability Rank is 2/10, and Growth Rank is 0/10, with a cash-to-debt ratio of 0.42. Return on equity stands at 1.27%, and return on assets is 1.23%, with an Altman Z Score of 0.00.
Stock Performance and Technical Indicators
Since the transaction date, HLXC has declined 1.33%, while gaining 1.56% since its IPO and 1.46% year-to-date. The stock's 14-day RSI is 31.16, with a 5-day RSI of 11.95 and a 9-day RSI of 23.49, suggesting oversold conditions. The 6-1 month momentum index is 4.85, with a Momentum Rank of 138 and an RSI 14-day rank of 80. These technical indicators suggest the stock may be nearing a short-term bottom, though the low GF Value Rank of 0/10 underscores the difficulty in assessing fundamental value for a shell company.
Industry Context and Largest Shareholder
HLXC operates in the Diversified Financial Services industry, a sector where SPACs seek target companies for business combinations. Leucadia National is the largest guru shareholder of HLXC, holding the most shares among tracked investors. The transaction reflects Sculptor Capital LP's continued interest in the SPAC, though the firm's overall position remains modest relative to its $9.56 billion equity portfolio. The SPAC market has seen varying levels of activity, and the presence of institutional investors like Sculptor Capital LP and Leucadia National suggests ongoing confidence in the vehicle's potential to identify and merge with a suitable target.
Transaction Analysis and Portfolio Implications
The addition of 56,000 shares by Sculptor Capital LP represents a measured increase in exposure to HLXC. While the 6.42% increase in position size is notable, the position remains a small fraction of the firm's overall portfolio at 0.1%. According to GuruFocus's Premium Guru 13F Ownership data, 1 guru currently holds the stock, with 0 adding and 0 trimming positions in recent quarters. This exclusive ownership signal, which is not available on platforms like Simply Wall St or Morningstar, indicates that Sculptor Capital LP is currently the sole tracked guru investor in HLXC. The transaction may signal the firm's anticipation of a potential business combination announcement, a common catalyst for SPAC share price appreciation.
For value investors monitoring SPAC activity, the key takeaway is the continued institutional interest in HLXC despite its low GF Score and lack of fundamental operating metrics. The firm's move could be interpreted as a speculative position on a future merger, rather than a traditional value investment based on earnings or cash flow. As with all SPAC investments, the ultimate outcome depends on the identification and successful execution of a business combination, which remains uncertain. GuruFocus will continue to track 13F filings and provide updates on institutional positioning in HLXC and other SPACs.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
